Drug-coated stent for coronary arteries (Sirolimus) - Vietnam Registration 2402802ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Drug-coated stent for coronary arteries (Sirolimus) in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402802ĐKLH/BYT-HTTB and manufactured by CG Bio Co., Ltd.. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN DAEWOONG PHARMACEUTICAL CO., LTD. TẠI THÀNH PHỐ HỒ CHÍ MINH.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2402802ĐKLH/BYT-HTTB
000.00.04.G18-220812-0015
Theo theo phụ lục
Theo phụ lục
Technical Details
The product is used as a stent to maintain the patency of the coronary artery by being placed at the site of the original lesion (the initial lesion) in the coronary artery of the patient with chronic myocardial ischemia. The stent has a tubular structure and is expandable. It can be used in conjunction with a balloon catheter, ... to reduce restenosis.
Dates and Status
Oct 22, 2024